Consultation - Maximum residue limit (MRL) proposal for Amprolium, Bacitracin, Cloxacillin, Dichlorvos, Erythromycin, Gamithromycin, Meloxicam, Novobiocin, Penicillin G, and Toltrazuril

The Veterinary Drugs Directorate (VDD) of Health Products and Food Branch, Health Canada, is considering regulatory amendment which may be of interest to you.  More specifically, the VDD is proposing to establish Maximum Residue Limits (MRLs) in Table III Division 15, Part B of the Food and Drug Regulations for Amprolium, Bacitracin, Cloxacillin,  Dichlorvos, Erythromycin, Gamithromycin, Meloxicam, Novobiocin, Penicillin G and Toltrazuril in edible tissues of food-producing animals.

How to Get Involved

This consultation is open for comment starting August 12, 2011 until November 9, 2011. Please select and read through the link below titled "Letter to Stakeholders". Once read please submit your comments via e-mail or by mail to:

consultationVDD-DMV@hc-sc.gc.ca

Consultations - Veterinary Drugs Directorate
Policy, Regulatory and International Affairs Division
Veterinary Drugs Directorate,
Health Products and Food Branch, Health Canada
Holland Cross Complex
11 Holland Ave.
Ground Floor, Suite 14
Ottawa, Ontario
K1A 0K9

Fax: (613) 957-3861

Consultation Document

Interested parties are encouraged to provide comments and suggestions by November 9, 2011.

Reporting to Canadians

After careful consideration of the comments received from the 90-day consultation period, the proposed MRLs will be published in the Canada Gazette, Part I.

If you have any questions, contact us at: consultationVDD-DMV@hc-sc.gc.ca.